According to Odaily Planet Daily, the stock price of cancer drug developer MEI Pharma nearly doubled in the days leading up to its mid-July announcement of a $100 million crypto treasury strategy. At the time, the company had not filed any major updates with the U.S. Securities and Exchange Commission, issued no press releases, and there was little discussion on social media, leading to market suspicions of insider trading. (Fortune)